Levalbuterol Oral Inhalation
Levalbuterol is an inhaled bronchodilator used to treat or prevent bronchospasm (sudden airway tightening) in people with reversible obstructive airway disease, such as asthma.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 22 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Levalbuterol inhalation solution concentrate is for use with a nebulizer only — it must never be swallowed or injected. The concentrate form must be diluted with sterile normal saline before it is put into the nebulizer. Follow the instructions for use carefully. Using it the wrong way or in the wrong device could result in receiving the wrong amount of medicine.
📖 Levalbuterol Oral Inhalation: Patient Information Guide
A plain-language walkthrough of Levalbuterol Oral Inhalation — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Levalbuterol oral inhalation is used to treat or prevent bronchospasm — sudden, tight narrowing of the airways — in people with reversible obstructive airway disease.
- Xopenex (levalbuterol HCl) inhalation solution concentrate is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease, including asthma
- Levalbuterol inhalation solution is not indicated for children under 6 years of age — clinical trials in this age group did not show effectiveness and showed more asthma-related side effects
⚙️How it works▾
Levalbuterol targets beta-2 receptors on the smooth muscle that wraps around the airways. When it binds to these receptors, it sets off a chemical chain reaction inside the muscle cells that lowers calcium levels and prevents the muscles from contracting — so the airways relax and widen, making it easier to breathe. This effect works throughout the airways, from the main windpipe down to the smallest breathing tubes. Levalbuterol can also help block the release of substances from immune cells (mast cells) in the airways that would otherwise trigger further tightening.
Because there are also some beta receptors in the heart, levalbuterol — like all medicines in this class — can affect heart rate and blood pressure in some people, especially at higher doses.
💊How it's taken▾
Levalbuterol inhalation solution is breathed in through a nebulizer, typically three times a day. The concentrate form must always be diluted with sterile normal saline before use. It can be taken with or without food, since it is inhaled and not swallowed. Children ages 6–11 use a lower dose than adults and adolescents 12 and older — always follow your prescriber's specific instructions.
- Adults and adolescents 12 and older: typically three times a day, every 6 to 8 hours
- Children 6–11 years: typically three times a day at a lower dose than adults
- Do not exceed the recommended dose
- If a dose is missed, take it as soon as you remember — but if it is almost time for the next dose, skip the missed one and resume your regular schedule
🤒Side effects — in detail▾
The most commonly reported side effects with levalbuterol inhalation include:
- Nervousness
- Tremor (shakiness, especially in the hands)
- Headache
- Dizziness
- Fast heartbeat (tachycardia)
- Palpitations (awareness of your heartbeat)
- Chest pain
- Runny or stuffy nose
- Increased cough
- Nausea or upset stomach
Stop using the medicine and get medical help right away if you have sudden worsening of breathing after a dose, signs of a serious allergic reaction (hives, swelling, difficulty breathing), chest pain, or a very fast or irregular heartbeat.
⚠️Warnings & precautions▾
- Paradoxical bronchospasm: In rare cases, levalbuterol can cause the airways to tighten suddenly right after use — the opposite of what it should do. This is life-threatening. Stop using it and seek emergency care immediately. It can happen on the very first use of a new vial.
- Do not overuse: Fatalities have been reported with excessive use of inhaled medicines like levalbuterol. Never exceed the prescribed dose. Needing extra doses more often than usual means your asthma may be worsening — call your doctor.
- Not a replacement for anti-inflammatory treatment: Levalbuterol opens the airways but does not reduce airway inflammation. Many people with asthma also need an inhaled corticosteroid. Using levalbuterol alone may not be enough to control asthma long-term.
- Heart effects: This medicine can raise heart rate and blood pressure, and may cause ECG (heart rhythm) changes. Use with extra caution if you have any heart condition.
- Low potassium (hypokalemia): Levalbuterol can temporarily lower potassium levels in the blood, which may affect heart rhythm. This is usually short-lived but important to monitor if you are also taking diuretics.
- Blood sugar changes: This medicine can raise blood glucose — important to know if you have diabetes.
🔀What it interacts with▾
Levalbuterol can interact with several types of medicines. Tell your doctor and pharmacist about everything you take:
- Other short-acting inhaled bronchodilators or epinephrine: Combining them increases the risk of heart side effects — avoid using together
- Beta-blockers (e.g., metoprolol, propranolol, atenolol): These can block levalbuterol from working and may cause dangerous airway tightening in people with asthma — generally should not be used together
- Diuretics (water pills, especially loop or thiazide types like furosemide or hydrochlorothiazide): Can worsen low potassium and heart rhythm changes caused by levalbuterol
- Digoxin: Levalbuterol may lower blood levels of digoxin — monitoring is recommended
- MAO inhibitors (e.g., phenelzine, selegiline) and tricyclic antidepressants (e.g., amitriptyline, nortriptyline): These intensify levalbuterol's effects on the cardiovascular system — use with extreme caution, and ideally wait 2 weeks after stopping these drugs before starting levalbuterol
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use levalbuterol if you have ever had a serious allergic reaction (including hives, swelling, anaphylaxis, or bronchospasm) to levalbuterol, albuterol, or any ingredient in the product
- Tell your doctor if you have a heart condition — including coronary artery disease, irregular heartbeat (arrhythmia), or high blood pressure — as levalbuterol can affect heart rate and rhythm
- Tell your doctor if you have diabetes — this medicine can raise blood sugar levels
- Tell your doctor if you have hyperthyroidism (an overactive thyroid) or a seizure disorder
- Tell your doctor if you are pregnant — uncontrolled asthma in pregnancy carries risks for both mother and baby, and your doctor will help find the right balance; a pregnancy registry exists to monitor outcomes (1-877-311-8972)
- Tell your doctor if you are breastfeeding — it is unknown whether levalbuterol passes into human milk
- Levalbuterol inhalation solution is not approved for children under 6 years of age
- Tell your doctor about all prescription and over-the-counter medicines, vitamins, and supplements you take
🚑If you take too much▾
Taking too much levalbuterol can cause exaggerated side effects, including rapid heart rate (up to 200 beats per minute), irregular heartbeat, seizures, very high or very low blood pressure, severe tremor, nervousness, headache, nausea, dizziness, and dangerously low potassium levels. In the most serious cases, cardiac arrest and death have been associated with overuse of inhaled sympathomimetic drugs. If you think you or someone else has used too much, call 911 or Poison Control immediately and stop using the medicine.
📡Pharmacodynamics — effects in the body▾
Levalbuterol produces measurable bronchodilation (airway opening) that can be detected within minutes of inhalation. In clinical studies in adults with asthma, all tested doses produced significantly more bronchodilation than placebo, as measured by improvement in lung function (FEV1 — the amount of air you can forcefully exhale in one second). The medicine also temporarily raises heart rate and blood glucose and lowers potassium levels in the blood; these changes are generally dose-related and tend to diminish with regular use over time. It also offers some protection against triggers that can cause the airways to tighten.
🔬Pharmacokinetics — how your body processes it▾
After inhalation, levalbuterol is absorbed into the bloodstream relatively quickly, with peak blood levels typically reached within about 12 minutes. The active form of the medicine (R-albuterol) has a half-life of roughly 3 to 4 hours in adults — meaning the body clears half of it in that time. It is primarily broken down in the gastrointestinal tract and liver, and most of it (80–100%) leaves the body through the kidneys in urine, either as unchanged drug or as a metabolite. In children ages 6–11, drug exposure (the total amount in the bloodstream) is somewhat higher than in adults at the same dose, which is why children use a lower dose.
📦How to store it▾
Store Levalbuterol Inhalation Solution USP in the protective foil pouch at 20° to 25°C (68° to 77°F) . Protect from light and excessive heat.
📄 Written from Levalbuterol Oral Inhalation’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Levalbuterol Oral Inhalation — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is levalbuterol used for? ▾
How do I use the nebulizer solution correctly? ▾
What side effects should I expect, and which ones mean I should call the doctor? ▾
If I need to use it more often than usual, can I just take extra doses? ▾
Can I use this medicine if I'm pregnant or breastfeeding? ▾
Are there medicines I should avoid while using levalbuterol? ▾
Is Levalbuterol Oral Inhalation available over the counter? ▾
When was Levalbuterol Oral Inhalation first available? ▾
Who makes Levalbuterol Oral Inhalation? ▾
💬 Answers drafted from Levalbuterol Oral Inhalation’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Levalbuterol Oral Inhalation comes
Levalbuterol Oral Inhalation is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Inhalation solution (nebulizer)
How this form is used
- Xopenex (levalbuterol HCl) inhalation solution concentrate is used to treat or prevent bronchospasm in adults, adolescents, and children 6 years and older with reversible obstructive airway disease
- Xopenex inhalation solution is not approved for children under 6 years of age
- Xopenex inhalation solution concentrate must be diluted with sterile normal saline before use in a nebulizer
- Xopenex inhalation solution is administered using a standard jet nebulizer with a face mask or mouthpiece connected to an air compressor
- Xopenex inhalation solution is typically used three times a day — follow your prescriber's instructions for timing
- Do not mix Xopenex inhalation solution with other medications in the nebulizer, as compatibility has not been established
Inhaler
📊 Levalbuterol Oral Inhalation across the U.S. market
How Levalbuterol Oral Inhalation appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Levalbuterol Oral Inhalation is used
A general measure of how commonly Levalbuterol Oral Inhalation is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Levalbuterol Oral Inhalation is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Levalbuterol Oral Inhalation prescribed? Of the 1,596 medications we measure, Levalbuterol Oral Inhalation ranks #393 by Medicaid prescriptions — more than 75% of them.
Utilization by Levalbuterol Oral Inhalation product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler Most dispensed
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 745791
levalbuterol 0.21 MG/ML Inhalation Solution
Summed across the 6 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311286
levalbuterol 0.417 MG/ML Inhalation Solution
Summed across the 6 of 32 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 242754
levalbuterol 0.103 MG/ML Inhalation Solution
Summed across the 6 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349590
levalbuterol 2.5 MG/ML Inhalation Solution
Summed across the 1 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1855389
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Levalbuterol Oral Inhalation, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 21 of 113 listed Levalbuterol Oral Inhalation NDCs with Medicaid activity.
🔍 Compare Levalbuterol Oral Inhalation products
A representative set of FDA-listed product records for Levalbuterol Oral Inhalation — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation solution (nebulizer) | ||||
| 0.63 mg/3 mL | Respiratory (inhalation) | A-S Medication Solutions | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Akorn | NDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Akorn | NDA | View NDC → |
| 1.25 mg/0.5 mL | Respiratory (inhalation) | Akorn | NDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Akorn | NDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Amneal Pharmaceuticals of New York LLC × 2 listings | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Amneal Pharmaceuticals of New York LLC × 2 listings | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Amneal Pharmaceuticals of New York LLC × 2 listings | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 1.25 mg/0.5 mL | Respiratory (inhalation) | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Burel Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Burel Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Burel Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.25 mg/0.5 mL | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | NorthStar RxLLC | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | NorthStar RxLLC | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | NorthStar RxLLC | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | Find on DailyMed ↗ |
| 0.31 mg/3 mL | Respiratory (inhalation) | Prasco Laboratories | NDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Prasco Laboratories | NDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Prasco Laboratories | NDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Proficient Rx LP | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Redpharm Drug × 2 listings | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Ritedose Pharmaceuticals, LLC × 3 listings | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Ritedose Pharmaceuticals, LLC × 3 listings | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Ritedose Pharmaceuticals, LLC × 3 listings | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.31 mg/3 mL | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 0.63 mg/3 mL | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1.25 mg/0.5 mL | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1.25 mg/3 mL | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 💊Inhaler | ||||
| 45 mcg | Oral | Actavis Pharma, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 45 mcg | Oral | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| 45 mcg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 45 mcg | Oral | Proficient Rx LP × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 45 mcg | Oral | Sunovion Pharmaceuticals Inc. | NDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Aarti Pharmalabs Limited | BULK INGREDIENT | View NDC → |
| 1 kg | — | Catalent Micron Technologies, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 4 kg/4 kg | — | Cipla Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Fine Chemicals Corporation (PTY) Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Olon SpA | BULK INGREDIENT | View NDC → |
| 100 kg/100 kg | — | SICOR Societa' Italiana Corticosteroidi s.r.l. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Sterling Pharma Solutions Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Sun Pharmaceutical Industries, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 83 of 83 products — FDA National Drug Code Directory. See every product, package size and price: browse all 83 Levalbuterol Oral Inhalation NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Levalbuterol Oral Inhalation — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Levalbuterol Oral Inhalation in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Levalbuterol Oral Inhalation went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 237159 2 dose forms · 5 strengths
-
Dose form (SCDF) Inhalation Solution RxCUI 2108209In current FDA listingsClinical drug / strength (SCD) 0.103 MG/MLRxCUI 3495900.21 MG/MLRxCUI 3112860.417 MG/MLRxCUI 2427542.5 MG/MLRxCUI 1855389 -
Dose form (SCDF) Metered Dose Inhaler RxCUI 745790In current FDA listingsClinical drug / strength (SCD) 200 ACTUAT levalbuterol 0.045 MG/ACTUATRxCUI 745791
Look up RxCUI 237159 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Levalbuterol Oral Inhalation is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 3 more on the FDA NDC directory.
RxNorm drug class
Levalbuterol Oral Inhalation belongs to the beta2-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 22 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.